kabutan

TAIKO PHARMACEUTICAL CO., LTD.(4574) Financial Results

4574
TSE Prime
TAIKO PHARMACEUTICAL CO., LTD.
287
JPY
-3
(-1.03%)
Oct 10, 3:30 pm JST
1.87
USD
Oct 10, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
Current Period Guidance
Annual
Result
Guidance History
Growth Rate
Profitability
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2021 11,299 -4,947 -6,131 -9,594 -220.5 0 Feb 18, 2022 J-GAAP
Dec, 2022 5,040 -3,079 -3,352 -4,895 -112.3 0 Feb 10, 2023 J-GAAP
Dec, 2023 6,120 -1,005 -1,248 -3,611 -76.3 0 Feb 9, 2024 J-GAAP
Dec, 2024 6,292 629 688 898 17.9 0 Feb 13, 2025 J-GAAP
Dec, 2025 Guidance 6,300 215 200 450 9.0 Aug 20, 2025 J-GAAP
YoY +0.1% -65.8% -70.9% -49.9% -49.9%
All-Time High
Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS
Record 14,966 3,824 3,633 2,453 57.6
Fiscal Year Mar, 2020 Mar, 2020 Mar, 2020 Mar, 2020 Mar, 2020
Second Half
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2022 3,183 -662 -837 -2,097 -48.1 0 Feb 10, 2023 J-GAAP
Jul - Dec, 2023 3,632 -609 -738 -3,097 -65.4 0 Feb 9, 2024 J-GAAP
Jul - Dec, 2024 3,432 147 160 134 2.7 0 Feb 13, 2025 J-GAAP
Jul - Dec, 2025 Guidance 3,888 169 180 171 3.4 Aug 20, 2025 J-GAAP
YoY +13.3% +15.0% +12.5% +27.6% +27.3%
Cash Flow
Annual
Fiscal Year Operating Profit Fee Cash Flow Operating Cash Flow Investing Cash Flow Financial Cash Flow Cash & Equivalents Cash Ratio Accounting Standards
Dec, 2022 -3,079 -1,804 -1,994 190 -997 2,797 18.59 J-GAAP
Dec, 2023 -1,005 859 -307 1,166 1,539 5,244 39.67 J-GAAP
Dec, 2024 629 357 362 -5 -1,181 4,532 35.09 J-GAAP
Actual Performance and Financial Trends
Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Jun, 2023 2,488 -396 -510 -514 -11.4 Aug 10, 2023 J-GAAP
Jan - Jun, 2024 2,860 482 528 764 15.2 76.7 Aug 9, 2024 J-GAAP
Jan - Jun, 2025 2,412 46 20 279 5.6 10.0 Aug 8, 2025 J-GAAP
YoY -15.7% -90.5% -96.2% -63.5% -63.5%
Quarterly Results
Result
Growth Rate
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2023 1,929 -48 -79 -48 -1.0 -2.5 Nov 10, 2023 J-GAAP
Oct - Dec, 2023 1,703 -561 -659 -3,049 -64.4 -32.9 Feb 9, 2024 J-GAAP
Jan - Mar, 2024 1,377 214 229 472 9.4 15.5 May 10, 2024 J-GAAP
Apr - Jun, 2024 1,483 268 299 292 5.8 18.1 Aug 9, 2024 J-GAAP
Jul - Sep, 2024 1,719 244 177 -50 -1.0 14.2 Nov 8, 2024 J-GAAP
Oct - Dec, 2024 1,713 -97 -17 184 3.7 -5.7 Feb 13, 2025 J-GAAP
Jan - Mar, 2025 1,150 44 11 292 5.8 3.8 May 9, 2025 J-GAAP
Apr - Jun, 2025 1,262 2 9 -13 -0.3 0.2 Aug 8, 2025 J-GAAP
YoY -14.9% -99.3% -97.0%
All-Time High Quarterly Results
Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS
Record 6,615 2,757 2,702 1,870 43.6
Fiscal Year Dec, 2020 Jun, 2020 Jun, 2020 Jun, 2020 Jun, 2020
Key Balance Sheet Figures
Fiscal Year BPS Equity Ratio Total Asset Equity Retained Earnings Interest-Bearing Debt Ratio Announce Accounting Standards
Dec, 2022 184.60 53.5 15,046 8,044 5,239 0.47 Feb 10, 2023 J-GAAP
Dec, 2023 134.93 51.0 13,220 6,739 1,628 0.48 Feb 9, 2024 J-GAAP
Dec, 2024 158.67 61.7 12,914 7,964 2,526 0.25 Feb 13, 2025 J-GAAP
Jan - Jun, 2025 68.0 11,680 7,948 2,806 0.17 Aug 8, 2025 J-GAAP